收费全文 | 5571篇 |
免费 | 461篇 |
国内免费 | 57篇 |
耳鼻咽喉 | 58篇 |
儿科学 | 218篇 |
妇产科学 | 101篇 |
基础医学 | 557篇 |
口腔科学 | 130篇 |
临床医学 | 636篇 |
内科学 | 1336篇 |
皮肤病学 | 83篇 |
神经病学 | 370篇 |
特种医学 | 560篇 |
外科学 | 699篇 |
综合类 | 153篇 |
一般理论 | 23篇 |
预防医学 | 499篇 |
眼科学 | 76篇 |
药学 | 321篇 |
中国医学 | 32篇 |
肿瘤学 | 237篇 |
2023年 | 33篇 |
2022年 | 44篇 |
2021年 | 86篇 |
2020年 | 49篇 |
2019年 | 62篇 |
2018年 | 77篇 |
2017年 | 94篇 |
2016年 | 87篇 |
2015年 | 91篇 |
2014年 | 144篇 |
2013年 | 195篇 |
2012年 | 220篇 |
2011年 | 208篇 |
2010年 | 182篇 |
2009年 | 196篇 |
2008年 | 212篇 |
2007年 | 327篇 |
2006年 | 278篇 |
2005年 | 266篇 |
2004年 | 216篇 |
2003年 | 192篇 |
2002年 | 181篇 |
2001年 | 172篇 |
2000年 | 181篇 |
1999年 | 165篇 |
1998年 | 138篇 |
1997年 | 120篇 |
1996年 | 126篇 |
1995年 | 89篇 |
1994年 | 87篇 |
1993年 | 80篇 |
1992年 | 140篇 |
1991年 | 123篇 |
1990年 | 118篇 |
1989年 | 102篇 |
1988年 | 107篇 |
1987年 | 89篇 |
1986年 | 116篇 |
1985年 | 105篇 |
1984年 | 62篇 |
1983年 | 58篇 |
1982年 | 39篇 |
1981年 | 40篇 |
1980年 | 33篇 |
1979年 | 40篇 |
1978年 | 31篇 |
1977年 | 24篇 |
1976年 | 32篇 |
1975年 | 27篇 |
1972年 | 27篇 |
Objective
To investigate how oncologists can balance explicit with general and realistic with hopeful information when discussing various topics at the transition from curative to palliative care in breast cancer.Methods
Qualitative analysis of focus groups consisting of female breast cancer survivors and healthy women.Results
Perceptions of survivors and healthy women largely overlapped. Participants thought that oncologists can help patients regain a future perspective during this consultation. To achieve this, four themes seemed important: honest medical information, availability of continued support, hope has many faces, and space to choose. Moreover, participants stressed they would need time to let the message sink in before any further information was provided.Conclusion
Participants thought that when confronted with this type of consultation they would need – more or less explicit – medical information and information regarding support. In order to maintain hope, knowledge about (treatment) possibilities is important, but also the certainty not to be abandoned by the hospital at a later stage of the disease and the confidence to remain able to make one's own decisions.Practice implications
A life-limiting diagnosis may shatter patients’ future perspective; however, this study provides suggestions for oncologists to create a new perspective. 相似文献Paroxysmal kinesigenic dyskinesia is an episodic movement disorder caused by dominant mutations in the proline-rich transmembrane protein PRRT2, with onset in childhood and typically with improvement or resolution by middle age. Mutations in the same gene may also cause benign infantile seizures, which begin in the first year of life and typically remit by the age of 2 years. Many details of PRRT2 function at the synapse, and the effects of mutations on neuronal excitability in the pathophysiology of epilepsy and dyskinesia, have emerged through the work of several groups over the last decade. However, the age dependence of the phenotypes has not been explored in detail in transgenic models. Here, we report our findings in heterozygous and homozygous Prrt2 knockout mice that recapitulate the age dependence of dyskinesia seen in the human disease. We show that Prrt2 deletion reduces the levels of synaptic proteins in a dose-dependent manner that is most pronounced at postnatal day 5 (P5), attenuates at P60, and disappears by P180. In a test for foot slippage while crossing a balance beam, transient loss of coordination was most pronounced at P60 and less prominent at age extremes. Slower traverse time was noted in homozygous knockout mice only, consistent with the ataxia seen in rare individuals with biallelic loss of function mutations in Prrt2. We thus identify three age-dependent phenotypic windows in the mouse model, which recapitulate the pattern seen in humans with PRRT2-related diseases.
相似文献